XML 20 R6.htm IDEA: XBRL DOCUMENT v3.3.1.900
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Series A preferred stock
Preferred Stock
Series A preferred stock
Additional Paid-In Capital
Series A preferred stock
Retained Earnings
Series A preferred stock
Preferred Stock
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Total
Balance at Dec. 31, 2012         $ 24,140 $ 101,354 $ 7,337 $ 8,773 $ 3,925 $ 145,529
Balance (in shares) at Dec. 31, 2012           25,307,110        
Increase (Decrease) in Stockholders' Equity                    
Repurchases of shares $ (20,725) $ (275)   $ (21,000)            
Repurchase of warrants             (1,575)     (1,575)
Accretion on Series A preferred stock $ 189   $ (189)              
Dividend on Series A preferred stock     $ (708) $ (708)            
Exercise of stock options           $ 138       138
Exercise of stock options (in shares)           33,757        
Share-based compensation             533     533
Tax benefit of share-based compensation           $ 19       19
Net issuance of restricted share awards (in shares)           56,913        
Net income               10,841   10,841
Other comprehensive (loss) income                 (7,350) (7,350)
Balance at Dec. 31, 2013         3,604 $ 101,511 6,020 18,717 (3,425) 126,427
Balance (in shares) at Dec. 31, 2013           25,397,780        
Increase (Decrease) in Stockholders' Equity                    
Issuance of common stock in MISN Transaction           $ 60,255       60,255
Issuance of common stock in MISN Transaction (in shares)           7,541,326        
Repurchases of shares           $ (387)       (387)
Repurchases of shares (in shares)           (51,732)        
Stock issuance costs             (381)     (381)
Conversion of Series C preferred stock         (2,548) $ 2,548 168 (168)    
Conversion of Series C preferred stock (in shares)           840,841        
Dividends declared ($0.08 and $0.23 per share) during the year ended December 31, 2014 and 2015, respectively               (2,742)   (2,742)
Exercise of stock options           $ 269       269
Exercise of stock options (in shares)           68,339        
Share-based compensation             993     993
Tax benefit of share-based compensation             184     184
Net issuance of restricted share awards (in shares)           108,506        
Net income               8,965   8,965
Other comprehensive (loss) income                 4,357 4,357
Balance at Dec. 31, 2014         1,056 $ 164,196 6,984 24,772 932 197,940
Balance (in shares) at Dec. 31, 2014           33,905,060        
Increase (Decrease) in Stockholders' Equity                    
Repurchases of shares           $ (28)       (28)
Repurchases of shares (in shares)           (3,696)        
Conversion of Series C preferred stock         $ (1,056) $ 1,056 70 (70)    
Conversion of Series C preferred stock (in shares)           348,697        
Dividends declared ($0.08 and $0.23 per share) during the year ended December 31, 2014 and 2015, respectively               (7,851)   (7,851)
Exercise of stock options           $ 293       293
Exercise of stock options (in shares)           56,432        
Share-based compensation             1,092     1,092
Tax benefit of share-based compensation             105     105
Net issuance of restricted share awards (in shares)           46,521        
Net income               15,349   15,349
Other comprehensive (loss) income                 (466) (466)
Balance at Dec. 31, 2015           $ 165,517 $ 8,251 $ 32,200 $ 466 $ 206,434
Balance (in shares) at Dec. 31, 2015           34,353,014